Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Johns

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Cardiology in the Young|December 1, 2010
The Senning operation for complete transposition: mid-term physiologic, electrophysiologic, and functional resultsW H Merrill, J R Stewart, J W Hammon, et al.
Journal of the American College of Cardiology|October 11, 1991
Echocardiographic estimation of critical left ventricular size in infants with isolated aortic valve stenosisM K Parsons, G A Moreau, T P Graham, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1992
Haemodynamic changes and physical performance at comparative levels of haemoglobin after long-term treatment with recombinant erythropoietinL P McMahon, J A Johns, A McKenzie, et al.
The American Journal of Cardiology|October 1, 1986
Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosisH D Garabedian, H K Gold, R C Leinbach, et al.
Australian and New Zealand Journal of Medicine|June 1, 1983
Amiodarone therapy for life threatening or refractory cardiac arrhythmiasJ A Johns, R W Harper, P J Currie, et al.
Circulation|April 1, 1986
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activityG J Hasking, M D Esler, G L Jennings, et al.
Circulation|June 1, 1987
A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectorisH K Gold, J A Johns, R C Leinbach, et al.
Journal of the American College of Cardiology|March 1, 1987
Comparative properties of two clinical preparations of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarctionH D Garabedian, H K Gold, R C Leinbach, et al.
Thrombosis Research|April 1, 1988
Laboratory monitoring of hemostasis during thrombolytic therapy with recombinant human tissue-type plasminogen activatorH D Garabedian, H K Gold, R C Leinbach, et al.
The American Journal of Cardiology|September 15, 1987
Detection of caval obstruction by magnetic resonance imaging after intraatrial repair of transposition of the great arteriesR M Campbell, G A Moreau, J A Johns, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Cardiology in the Young|December 1, 2010
The Senning operation for complete transposition: mid-term physiologic, electrophysiologic, and functional resultsW H Merrill, J R Stewart, J W Hammon, et al.
Journal of the American College of Cardiology|October 11, 1991
Echocardiographic estimation of critical left ventricular size in infants with isolated aortic valve stenosisM K Parsons, G A Moreau, T P Graham, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1992
Haemodynamic changes and physical performance at comparative levels of haemoglobin after long-term treatment with recombinant erythropoietinL P McMahon, J A Johns, A McKenzie, et al.
The American Journal of Cardiology|October 1, 1986
Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosisH D Garabedian, H K Gold, R C Leinbach, et al.
Australian and New Zealand Journal of Medicine|June 1, 1983
Amiodarone therapy for life threatening or refractory cardiac arrhythmiasJ A Johns, R W Harper, P J Currie, et al.
Circulation|April 1, 1986
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activityG J Hasking, M D Esler, G L Jennings, et al.
Circulation|June 1, 1987
A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectorisH K Gold, J A Johns, R C Leinbach, et al.
Journal of the American College of Cardiology|March 1, 1987
Comparative properties of two clinical preparations of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarctionH D Garabedian, H K Gold, R C Leinbach, et al.
Thrombosis Research|April 1, 1988
Laboratory monitoring of hemostasis during thrombolytic therapy with recombinant human tissue-type plasminogen activatorH D Garabedian, H K Gold, R C Leinbach, et al.
The American Journal of Cardiology|September 15, 1987
Detection of caval obstruction by magnetic resonance imaging after intraatrial repair of transposition of the great arteriesR M Campbell, G A Moreau, J A Johns, et al.
Pageof 4